Loading...
NPI 1316983158 · Seattle, WA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Quest Diagnostics Clinical Laboratories Inc is a clinical medical laboratory provider located in Seattle, Washington. This profile covers 392 Medicare and 486 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Quest Diagnostics Clinical Laboratories Inc |
| Address | 1737 Airport Way S |
| City | Seattle |
| State | WA |
| ZIP | 98134 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 21, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $109.2M |
| Medicare | $10.6M |
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC presents as a high-volume clinical laboratory operation: its Medicare top CPTs are routine chemistry and phlebotomy codes such as 80053 ($1M revenue), 36415 ($923.1K revenue) and 80061 ($831.5K revenue), and its Medicaid top CPTs include high-volume molecular and panel tests such as U0003 ($8.5M revenue), 87491 ($5.3M revenue) and 87591 ($5.1M revenue). The mix — large counts for panels, NAATs, and specimen collection — indicates the provider operates broad outpatient specimen-processing and high-throughput testing services rather than a narrow specialty practice.
Revenue concentration differs by payer: the top three Medicare codes account for 36.8% of the provider's total Medicare revenue, while the top three Medicaid codes account for 26.8% of the provider's total Medicaid revenue. For Medicare the concentration is driven by routine panels and collection (80053, 36415, 80061), whereas for Medicaid the concentration centers on SARS-CoV-2 PCR testing and sexually transmitted infection NAATs (U0003, 87491, 87591).
Payer mix is heavily skewed toward Medicaid in scale: total Medicaid revenue is $109.2M versus total Medicare revenue of $10.6M, indicating Medicaid is the dominant revenue source by reported dollars. This makes the entity effectively a large Medicaid billing presence in Washington relative to its Medicare footprint.
National competitive standing on Medicare shows extreme volume for many routine lab codes: 80053 ranks #42 of 26416 providers nationally (100th percentile; extreme outlier) and 36415 ranks #37 of 86467 providers nationally (100th percentile; extreme outlier). Multiple additional Medicare codes (80061, 84443, 85025, 80048, 82728) also appear as 100th-percentile extreme outliers or notably above typical national volume, consistent with a major national-scale testing throughput for these assays.
Statewide competitive standing on Medicaid is dominant for many codes: U0003 ranks #4 of 103 providers in-state (97th percentile; notably above typical state volume), 80050 ranks #2 of 93 providers in-state (99th percentile; extreme outlier), and 80053 ranks #2 of 235 providers in-state (100th percentile; extreme outlier). The provider also ranks #1 or #2 for several high-volume Medicaid tests (87801, 86003, 87389, 80061), signaling a top-tier laboratory role across multiple test families in-state.
Specific code-level statistical outliers are numerous across both payers and test types. On Medicare, codes such as 80053, 36415, 80061, 84443, and 85025 are labeled 'extreme outlier' nationally; on Medicaid, codes including 80050, 80053, 80061, 84443, 85025, and 87801 are labeled 'extreme outlier' in-state. These labels indicate volumes far above typical peers for both routine chemistry/panels and infectious disease/molecular testing.
The provider handles a very large specimen volume as evidenced by massive claim counts on collection and common panels: Medicare claim counts include 101.1K for 80053 and 115.4K for 36415, while Medicaid claim counts include 563.8K for 80053 and 642.5K for 36415. High claim volumes paired with comparatively low per-claim payments on many Medicaid panel and collection codes (for example, 36415 at $2 avg paid/claim on Medicaid) are consistent with scale-based, high-throughput lab economics.
Operational tenure is long: the NPI was enumerated 2006-06-21 (~20 years ago), so the provider has an extended billing history. That tenure plus the observed national and in-state rank patterns supports interpretation of this entity as an established, high-throughput clinical laboratory with sustained market presence.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
392 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 101,130 | $10 | $1M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 115,390 | $10 | $923.1K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 63,960 | $10 | $831.5K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 50,570 | $20 | $809.1K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 82,630 | $10 | $661.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 12,970 | $30 | $376K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 37,560 | $10 | $375.6K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 6,350 | $40 | $253.8K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 13,860 | $20 | $207.9K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 10,730 | $20 | $193.1K |
Showing 1–10 of 392
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 392 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
486 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 119,950 | $70 | $8.5M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 213,990 | $30 | $5.3M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 214,270 | $20 | $5.1M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 11,970 | $420 | $5M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 210,020 | $20 | $4.8M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 119,200 | $40 | $4.5M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 77,340 | $60 | $4.5M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 563,820 | $10 | $3.4M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 421,330 | $10 | $3.4M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 317,930 | $10 | $2.9M |
Showing 1–10 of 486
How this provider's Medicaid billing volume and revenue compare to other Washington providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Washington median
486 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 20 | 1,010 | $140 | $3M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10 | 30 | 660 | $100 | $1.5M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 2 | 10 | 130 | $370 | $1.3M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 4 | 100 | 1,940 | $70 | $1M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 3 | 170 | 2,120 | $40 | $779.1K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 2 | 10 | 1,490 | $50 | $707.8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 4 | 90 | 1,760 | $50 | $601.4K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 20 | 1,110 | $130 | $509.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 3 | 120 | 2,040 | $30 | $464.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 3 | 120 | 2,020 | $30 | $441.1K |
Showing 1–10 of 486
Other providers in the same ZIP code as Quest Diagnostics Clinical Laboratories Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Evergreen Treatment Services | WA | Methadone Clinic | $428.2K | $5.4M |
| Phenopath Laboratories PLLC | WA | Clinical Medical Laboratory | $500.2K | $278.7K |
| Costco Wholesale Corporation | WA | Community/Retail Pharmacy | $154.5K | $0 |
| Shane Anderson | WA | Anatomic Pathology & Clinical Pathology Physician | $98.4K | $0 |
| Jason Appleberry | WA | Physician Assistant | $77K | $0 |
| Adam Saenz | WA | Anatomic Pathology & Clinical Pathology Physician | $69.9K | $0 |
| Aashiyana Koreishi | WA | Anatomic Pathology Physician | $67.9K | $0 |
| Angie Pham | WA | Anatomic Pathology & Clinical Pathology Physician | $63.4K | $0 |
| Linda Burkhardt | WA | Anatomic Pathology & Clinical Pathology Physician | $60.4K | $0 |
| Valentina Robila | WA | Cytopathology Physician | $56K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.